Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 643

cancer treatment

Prof. Dan Peer and research team at Tel Aviv University's Laboratory of Precision Nanomedicine. (Tel Aviv University)
March 17, 2025, 10:57 am
Israeli researchers use gene editing to eliminate 50% of head, neck tumors in mice
Tel Aviv University scientists say they can inject CRISPR genetic ‘molecular scissors’ to shrink tumors by 90%; researcher ‘optimistic’ about clinical trials in 2 to 3 years
By Diana Bletter
Naor Blankleder is fighting for his life following the metastasis of osteosarcoma in his knee to his lung. (Courtesy)
August 18, 2023, 8:58 pm
Israeli cancer patient in final push to raise money for specialized treatment in NY
Naor Blankleder, 29, thought he had beat bone cancer but now it has spread to his lungs and his best chance to survive lies with doctors and researchers at Memorial Sloan Kettering
By Renee Ghert-Zand
A doctor detects lung cancer on a scan (utah778 via iStock by Getty Images)
August 16, 2023, 8:42 pm
Israeli study may open door to preventing relapse of certain types of lung cancer
Researchers at Weizmann Institute studying mice identify genetic mutation as potential biomarker for successful treatment with existing drug
By Renee Ghert-Zand
Ronen Bar, head of the Shin Bet security service, at a memorial service marking 27 years since the assassination of late Prime Minister Yitzhak Rabin, held at Mount Herzl cemetery in Jerusalem on November 6, 2022. (Olivier Fitoussi/Flash90)
June 12, 2023, 1:53 pm
Daily Briefing June 12: Is it safe to use the Shin Bet to fight Arab violent crime?
Editor David Horovitz on U-20 World Cup tourney, MK Yair Lapid’s testimony and new efforts to stop wave of killings; health reporter Renee Ghert-Zand on uptick of youth smoking
By ToI Staff
Israeli security forces demolish the house of Palestinian terrorist Eslam Froukh, in the West Bank city of Ramallah, June 8, 2023. (Flash90)
June 11, 2023, 1:04 pm
Daily Briefing Jun 11: In rare move, IDF enters Ramallah. Why is this significant?
Military correspondent Emanuel Fabian with Lebanon border riot and uptick of violence in Arab communities; news editor Amy Spiro with two new stranger-than-fiction nonfiction books
By ToI Staff
File: Heads of opposition parties Labor MK Merav Michaeli, Yesh Atid head MK Yair Lapid, National Unity head MK Benny Gantz, Israel Beteinu head MK Avigdor Liberman and leader of the United Arab List MK Mansour Abbas hold a joint press conference in Tel Aviv, on March 16, 2023. (Avshalom Sassoni/Flash90)
June 8, 2023, 1:17 pm
Daily Briefing June 8: Opposition unites on judicial panel pick, but does it matter?
Knesset correspondent Carrie Keller-Lynn on squabbling ahead of Judicial Selection Committee vote; health reporter Renee Ghert-Zand on whooping cough outbreak, 1st case of progeria
By ToI Staff
'My Happy Ending,' Israeli film starring Andie MacDowell and in Israeli theaters as of June 1, 2023. (Courtesy)
June 3, 2023, 1:48 pm
Andie MacDowell stars in Israeli film about life choices, based on Cameri play
‘My Happy Place’ tells story about cancer, women and friendships in unlikely places
By Jessica Steinberg
Hadassah Medical Center staff assist a head and neck cancer clinical trial patient before she undergoes proton therapy by the P-Cure, Modiin Israel, April 2023. (Courtesy of P-Cure)
May 18, 2023, 10:12 am
Proton therapy, touted as cancer killer without side effects, set for Israel debut
Hadassah Medical Center partners with Israeli company P-Cure in study comparing treatment with traditional X-ray radiation; Ichilov inks deal for first proton therapy center
By Renee Ghert-Zand
The new facility for proton therapy at Hadassah Medical Center in Jerusalem; a patient in a chair wears a plastic mask that covers the face to protect it from radiation (Courtesy of Hadassah Medical Center)
July 8, 2022, 5:34 pm
New form of proton therapy for cancer starts trial in Jerusalem
Advanced radiation treatment uses innovative chair that can move patient 260 degrees to precisely target tunors with its high-energy beams
By Nathan Jeffay
A woman holds her crying child at the cancer ward of the Children's Hospital in Damascus, Syria, on Monday, March 7, 2022. (AP Photo/Omar Sanadiki)
April 3, 2022, 10:08 am
In war-torn Syria, a charity offers hope to kids with cancer
BASMA is the largest association within the country offering free cancer diagnoses and treatment, after conflict devastated the health care system
By OMAR SANADIKI
US First lady Jill Biden speaks as she visits the St. Jude Children's Research Hospital, Friday, March 25, 2022, in Memphis, Tenn. (AP Photo/Karen Pulfer Focht)
March 26, 2022, 3:16 am
Jill Biden visits St. Jude hospital, meets evacuated Ukrainian child cancer patients
Jewish couple who fled antisemitism in Soviet Union now leading efforts to help Tennessee children’s research hospital translate patients medical records to enable their treatment
By ADRIAN SAINZ
PROMOTED CONTENT
“We are going to be much more precise. We are going to provide treatment that has much fewer side effects,” says Prof. Aaron Ciechanover (OncoHost)
March 14, 2022, 5:14 pm
Lifting the veil of uncertainty around cancer treatments
Israeli startup OncoHost predicts which specialized therapies will be most effective for late-stage cancer
By Noa Shapira
Prof. Yoram Palti. (Peter Doyle)
February 23, 2022, 8:25 pm
Yoram Palti awarded Israel Prize for ‘groundbreaking’ cancer treatment
Technion professor recognized for helping to develop non-invasive treatment that fights various types of cancers using electric pulses
By ToI Staff
PROMOTED CONTENT
Technology patented by HIL Applied Medical, an Israeli startup, reduces the size and cost of cancer therapy that is currently out of reach for all but a tiny percentage of patients (HIL)
February 8, 2022, 3:36 pm
Israeli startup uses Hebrew U breakthrough to cut the cost of treating cancer
HIL Applied Medical hopes to make life-saving proton-beam radiotherapy affordable and accessible
By Lisa Gann
A radiologist uses a magnifying glass to check mammograms for breast cancer in Los Angeles, on May 6, 2010. (AP Photo/ Damian Dovarganes, File)
September 19, 2021, 7:47 pm
AstraZeneca announces ‘groundbreaking’ results in new breast cancer drug trial
72% of trial patients administered Enherthu showed no progression in their cancer after 12 months, compared to 34.1% of those treated with the current standard of care medication
By ToI Staff
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.